New research presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that people ...

New research presented at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that people with ...

Kalaris Therapeutics initiates a phase 1b/2 study for TH103, targeting neovascular age-related macular degeneration and ...

While pivotal research on therapies for neovascular age-related macular degeneration (nAMD) and geographic atrophy (GA) ...

OLN324 targets both VEGF and Ang2, the same mechanism of action as Roche’s Vabysmo, the Swiss giant’s multi-blockbuster ...

IRON MOUNTAIN — Garrett Eye Center in Iron Mountain is offering a new non-invasive treatment for early stage dry macular ...

The use of anticoagulants or antiplatelets was linked to a higher risk of intraocular hemorrhage requiring vitrectomy in ...

BrightFocus Foundation today launched two new national public service announcements, Stop AMD and Stop Glaucoma, to raise awareness of macular degeneration and glaucoma, leading causes of irreversible ...

Recently initiated Phase 1b/2 multiple ascending dose study intended to assess safety and efficacy in nAMD patients receiving four initial ...

The FDA has granted Fast Track Designation to Sanofi’s SAR402663, an investigational one-time intravitreal gene therapy for ...

Prior to this research study, only a single cross-sectional study was conducted to investigate the correlation between AMD ...